SYSTEM FÜR ABLATIONSTHERAPIE

Patent europeic · EP4322877 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4322877
Numer da la dumonda
EP22720846
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-04-2022
Publitgà
21-02-2024
Concedì
25-03-2026
La protecziun finescha il pli tard
10-04-2042
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
A61B 18/24 (2006.01)
A61B 17/34 (2006.01)
A61B 18/22 (2006.01)
A61B 18/28 (2006.01)
A61K 9/00 (2006.01)
A61K 41/00 (2020.01)
A61N 5/06 (2006.01)
A61N 5/067 (2006.01)
Prioritad
US 202163174431 P 13.04.2021
Dumonda PCT
PCT/US2022/024291 11.04.2022
Publicaziun PCT
WO2022/221208 20.10.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Possessur

Nanospectra Biosciences, Inc.

8285 El Rio Street, Suite 150, Houston, TX 77054, US

Inventur

SCHWARTZ, Jon, Alexander

Houston, Texas 77054, US

GOODRICH, Glenn, Patrick

Houston, Texas 77054, US

MURPHY, Andrew, Mark

Bend, Oregon 97703, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.